Longevity

January 10, 2018

Lifespan extension therapy: Candesartan, an angiotensin II receptor antagonist used mainly in the treatment of hypertension, may increase life span via up-regulation of its target gene BubR1, 10/January/2017, 7.02 pm

Lifespan extension therapy: Candesartan, an angiotensin II receptor antagonist used mainly in the treatment of hypertension, may increase life span via up-regulation of its target gene BubR1, 10/January/2017, 7.02 pm https://genomediscovery.org/wp-content/uploads/2018/01/Candesartan-may-promote-longevity-by-regulating-the-expression-of-a-number-of-longevity-promoting-molecules-figure-1-including-BuBR1.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/01/Candesartan-may-promote-longevity-by-regulating-the-expression-of-a-number-of-longevity-promoting-molecules-figure-1-including-BuBR1.jpg2_.jpg January 10, 2018 January 10, 2018

What they say: Introduction: A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and Department of Pharmacology, School…

January 10, 2018

Lifespan extension therapy: Atorvastatin (Trade name: Lipitor), a lipid-lowering agent, prolongs mammalian life span via down regulation of angiotensin II type I receptor (AT1R), 10/January/2017, 6.38 pm,

Lifespan extension therapy: Atorvastatin (Trade name: Lipitor), a lipid-lowering agent, prolongs mammalian life span via down regulation of angiotensin II type I receptor (AT1R), 10/January/2017, 6.38 pm, https://genomediscovery.org/wp-content/uploads/2018/01/Atorvastatin-may-decreae-blood-pressure-through-down-regualtino-of-AT1R.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/01/Atorvastatin-may-decreae-blood-pressure-through-down-regualtino-of-AT1R.jpg January 10, 2018 January 10, 2018

Significance of the study: It has been shown earlier that antagonizing angiotensin II type I receptor (AT1R) expression may prolong mammalian life span. Further, it has been shown that disruption of AT1R (AGTR1)…

January 9, 2018

Life-extension therapy: Tomatidine, isolated from unripe tomoto, inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 9/January/2017, 11.59 pm

Life-extension therapy: Tomatidine, isolated from unripe tomoto, inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 9/January/2017, 11.59 pm https://genomediscovery.org/wp-content/uploads/2018/01/Tomatidine-may-extend-lifespan-by-decreasing-p70S6-Kinase-expression.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/01/Tomatidine-may-extend-lifespan-by-decreasing-p70S6-Kinase-expression.jpg2_.jpg January 9, 2018 January 9, 2018

What they say: A study from the Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK shows that “Ribosomal protein S6 kinase 1…

January 9, 2018

Lifespan extension therapy: Telmisartan [Brand name: Micardis], an anit-hypertensive medication, increases life span via up-regulation of its target gene BubR1, 9/January/2017, 11.47 pm

Lifespan extension therapy: Telmisartan [Brand name: Micardis], an anit-hypertensive medication, increases life span via up-regulation of its target gene BubR1, 9/January/2017, 11.47 pm https://genomediscovery.org/wp-content/uploads/2018/01/Telmisartan-may-promote-longevity-by-regulating-the-expression-of-a-number-of-longevity-promoting-molecules-figure-1-including-BuBR11.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/01/Telmisartan-may-promote-longevity-by-regulating-the-expression-of-a-number-of-longevity-promoting-molecules-figure-1-including-BuBR11.jpg January 9, 2018 January 9, 2018

January 8, 2018

Lifespan extension therapy: Tomatidine, isolated from unripe tomato, among others, prolongs mammalian life span via down regulation of angiotensin II type I receptor (AT1R), 8/January/2017, 10.41 pm

Lifespan extension therapy: Tomatidine, isolated from unripe tomato, among others, prolongs mammalian life span via down regulation of angiotensin II type I receptor (AT1R), 8/January/2017, 10.41 pm https://genomediscovery.org/wp-content/uploads/2018/01/Tomatidine-may-decrease-blood-pressure-increase-insulin-sensitivity-decrease-cardiac-ageing-and-extend-lifespan-by-decreasing-AT1R-expression1.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/01/Tomatidine-may-decrease-blood-pressure-increase-insulin-sensitivity-decrease-cardiac-ageing-and-extend-lifespan-by-decreasing-AT1R-expression1.jpg January 8, 2018 January 8, 2018

January 7, 2018

Lifespan extension therapy: Tomatidine, a glycoalkaloid isolated from unripe tomato, increases life span via up-regulation of its target gene BubR1, 7/January/2017, 11.28 pm

Lifespan extension therapy: Tomatidine, a glycoalkaloid isolated from unripe tomato, increases life span via up-regulation of its target gene BubR1, 7/January/2017, 11.28 pm https://genomediscovery.org/wp-content/uploads/2018/01/Tomatidine-may-promote-longevity-by-regulating-the-expression-of-a-number-of-longevity-promoting-molecules-figure-1-including-BuBR11.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/01/Tomatidine-may-promote-longevity-by-regulating-the-expression-of-a-number-of-longevity-promoting-molecules-figure-1-including-BuBR11.jpg January 7, 2018 January 8, 2018